Intravenous thrombolytic therapy with rt-PA in acute stroke. Experiences from the clinical routine;Systemische thrombolysetherapie mit rt-PA beim akuten mediaterritorialinfarkt: Erfahrungen aus der klinischen routine

Nervenarzt

Volumn 70, Issue 4, 1999, Pages 330-334

  Ringleb, P A ^a   Bertram, M ^b   Willig, V ^b   Hacke, W ^b  

^a Neurologische Klinik   (Germany)

^b NONE

Author keywords

Plasminogen activator; Stroke; Thrombolytic therapy

Indexed keywords

ALTEPLASE;

ANGIOGRAPHY; ARTERY PERFUSION; ARTICLE; DOPPLER FLOWMETRY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PLASMINOGEN ACTIVATION; RECANALIZATION; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; CAROTID ARTERY THROMBOSIS; CAROTID ARTERY, INTERNAL; CEREBRAL INFARCTION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0032938384     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050444     Document Type: Article

References (16)

1. Adams HP, Brott T, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W (1996) Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 27:1711-1718
2. Brott T (1996) Thrombolysis for stroke. Arch Neurol 53:1305-1306
3. BrottT (1997) Reopening occluded cerebral arteries. In: Bogousslavsky J (ed) Acute stroke treatment. Martin Dunitz, pp 109-148
4. Caplan LR, Mohr JP, Kistler JP (1997) Should thrombolytic therapy be the first-line treatment for acute ischemic stroke. N Engl J Med 337:1309-1313
5. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC (1998) Intravenous tissue plasminogen activator for acute ischemic stroke. Stroke 29:18-22
6. Furlan AJ, Kanoti G (1997) When is thrombolysis justified in patients with acute ischemic stroke? A bioethical Perspektive. Stroke 28:214-218
7. Grond M, Rudolf J, Schmülling C, Stenzel C, Neveling M, Heiss W-D (1998) Can the NINDS results be transfered into daily routine? Stroke 29:288
8. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute stroke. JAMA 274:1017-1025
9. Lyden PD, Grotta JC, Levine SR, Marler JD, Frankel MR, Brott TG (1997) Intravenous thrombolysis for acute stroke. Neurology 49:14-29
10. Mori K, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42:976-982
11. NIH-Group (1996) Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 333:1581-1587
12. Rankin L (1957) Cerebral vascular accidents in patents over age 60, II: prognosis. Scott Med J 2:200-215
13. Riggs JE (1996) Tissue-type plasminogen activator should not be used in acute ischemic stroke. Arch Neurol 53:1306-1308
14. von Kummer R, Forsting M, Hacke W, Sartor K (1993) Recanalization, infarct volume, cerebral hemorrhage and clinical outcome after intravenous recombinant tissue plasminogen activator and heparin in acute carotid territory stroke. In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acite ischemic stroke II. Springer, Berlin Heidelberg New York, pp 53-58
15. Wildermuth S, Knauth M, Brandt T, Winter R, Sartor K, Hacke W (1998) Role of computerized tomography angiography (CTA) in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke 29:935-938
16. Yamaguchi T, Hayakawa T, Kikuchi H for the Japanes Thrombolysis Study Group (1993) Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebo-controlled, double-blind trial. In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II.Springer, Berlin Heidelberg New York, pp 59-65